Knowledge HQ

Publications

Accelerating CAR T cell manufacturing with an automated next-day process

The study presents a 24-hour CAR-T manufacturing workflow. T cell cultures were maintained in G-Rex vessels during isolation and transduction, and control 7-day expansions were also performed in G-Rex vessels.
Download Now
Publications

Detailed analysis of the effects of a NOT gate on activation and growth of T cells

Tmod cells maintain robust potency and selectivity. Transduced cells were cultured in G-Rex 24 well plates, and T cells for in vivo studies were cultured in G-Rex 6 well plates.
Download Now
Publications

Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors

The study describes the preclinical evaluation of TAC01-CLDN18.2 T cells. These cells were manufactured using purified CD4/CD8 T cells in a 9-day process utilizing either the G-Rex system from Wilson Wolf or the Cocoon platform.
Download Now
Publications

Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response

This study explores combining CAR T cells with 177Lu-DOTATATE targeted radionuclide therapy. CAR T cells were transduced and subsequently expanded in G-Rex 6M well plates.
Download Now
Publications

A Novel B7-H4xCD3 Bispecific T Cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune-Checkpoint Therapies

PF-07260437 demonstrates potent antitumor efficacy in breast cancer models. For adoptive T cell transfer studies, human T cells were expanded in a G-Rex cell culture device.
Download Now
Publications

Scalable process development of NK and CAR-NK expansion in a closed bioreactor

The authors developed a scalable process for expanding NK and CAR-NK cells using G-Rex 100M closed-system. The study showed that cells expanded in G-Rex 100M retained similar phenotypes and cytotoxicity to those grown in G-Rex 6-well plates.
Download Now
Publications

Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair

This paper reports a method leveraging HMEJ for Cas9-induced targeted integration of large DNA payloads. In the lentiviral transduction comparison arm, T cells were activated and transferred to a G-Rex 24-well plate for expansion.
Download Now
Publications

S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice

This study demonstrates that S309-CAR-NK cells can bind to SARS-CoV-2 variants and reduce viral loads in humanized ACE2-NSG mice. Primary NK cell expansion and CAR-NK cell maintenance were performed using G-REX wells.
Download Now
Publications

A synthetic cytotoxic T cell platform for rapidly prototyping TCR function

This study introduces the YT-rCTL/KFRET system for rapid TCR functional profiling. YT-Indy based effector cell lines were subcultured in 24-well G-Rex plates. The platform allows for the recombinant expression of TCRs and antigens to assess cytotoxic responses via a granzyme-activatable reporter.
Download Now
Publications

CAR-T cell expansion platforms yield distinct T cell differentiation states

This study compares CAR-T expansion in Prodigy, Xuri, G-Rex, and bags. G-Rex (500M) cultures yielded effector memory-enriched cells. Hypoxic culture in G-Rex increased the proportion of naïve/stem central memory-like cells, suggesting oxygenation is a key factor in T cell differentiation during manufacturing.
Publications

Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia

This study demonstrates that proteasome inhibitors sensitize AML cells to NK cell killing. NK cells were activated by co-culture with irradiated feeder cells in G-Rex 10 vessels. The combination of bortezomib pre-treatment and CAR-NK infusion significantly delayed tumor growth and prolonged survival in xenograft models.
Download Now
Publications

Placental circulating T cells: a novel, allogeneic CAR- T cell platform with preserved T- cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC- derived CAR- T

This study identifies placental circulating T cells as a superior source for allogeneic CAR-T therapy. T cells were activated and expanded in G-Rex plates. The resulting CAR-T cells retained stemness markers, exhibited a favorable cytokine profile, and demonstrated durable in vivo efficacy against lymphoma.
Download Now